Ultrasound elastography of the prostate: State of the art

Diagnostic and Interventional Imaging

Volumn 94, Issue 5, 2013, Pages 551-560

  Correas, J M ^a,b,c   Tissier, A M ^b   Khairoune, A ^b   Khoury, G ^a,b   Eiss, D ^b   Helenon O ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c CNRS   (France)

Author keywords

Elastography; Prostate biopsy; Prostate cancer; Shear wave elastography; Strain elastography

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; ARTIFACT; CANCER GRADING; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER TISSUE; DIAGNOSTIC IMAGING; DIGITAL RECTAL EXAMINATION; ELASTOGRAPHY; GLEASON SCORE; HUMAN; INVASIVE PROCEDURE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PROSTATE BIOPSY; PROSTATE CANCER; QUASI STATIC ELASTOGRAPHY; RIGIDITY; SENSITIVITY AND SPECIFICITY; SHEAR WAVE ELASTOGRAPHY; ULTRASOUND; ULTRASOUND ELASTOGRAPHY; ULTRASOUND TRANSDUCER;

AGED; BIOPSY; ELASTICITY IMAGING TECHNIQUES; ENDOSONOGRAPHY; FEMALE; HARDNESS; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MASS SCREENING; MIDDLE AGED; NEOPLASM GRADING; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84892573709     PISSN: None     EISSN: 22115684     Source Type: Journal    
DOI: 10.1016/j.diii.2013.01.017     Document Type: Short Survey

References (51)

1. American Cancer Society. 2012 Estimates for Cancer Incidence. American Cancer Society; 2012.
2. HAS. Cancer de la prostate: identification des facteurs de risque et pertinence d'un dépistage par dosage de l'antigène spécifique prostatique (PSA) de populations d'hommes à haut risque ? Haute Autorité de santé; 2012 http://www.hassante. fr/portail/jcms/c 1238318/fr/cancer-de-la-prostateidentification-des-facteurs- de-risque-et-pertinence-dundepistage-par-dosage-de-lantigene-specifique-de-la- prostatepsa-de-populations-dhommes-a-haut-risque
3. Ahmed HU, Arya M, Freeman A, Emberton M. Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy? The lancet oncology 2012;13(11):e509-17.
4. Kelloff GJ, Choyke P, Coffey DS, Prostate Cancer Imaging Working Group. Challenges in clinical prostate cancer: role of imaging. AJR Am J Roentgenol 2009;192(6):1455-70.
5. Mian BM, Naya Y, Okihara K, Vakar-Lopez F, Troncoso P, Babaian RJ. Predictors of cancer in repeat extended multisite prostate biopsy in men with previous negative extended multisite biopsy. Urology 2002;60(5):836-40. (Pubitemid 35300350)
6. Singh H, Canto EI, Shariat SF, Kadmon D, Miles BJ, Wheeler TM, et al. Predictors of prostate cancer after initial negative systematic 12 core biopsy. J Urol 2004;171(5): 1850-4. (Pubitemid 38501021)
7. Djavan B, Remzi M, Marberger M. When to biopsy and when to stop biopsying. Urol Clin North America 2003;30(2):253-62, viii. (Pubitemid 36522784)
8. Delongchamps NB, Haas GP. Saturation biopsies for prostate cancer: current uses and future prospects. Nat Rev Urol 2009;6(12):645-52.
9. Giannarini G, Autorino R, di Lorenzo G. Saturation biopsy of the prostate: why saturation does not saturate. Eur Urol 2009;56(4):619-21.
10. Ashley RA, Inman BA, Routh JC, Mynderse LA, Gettman MT, Blute ML. Reassessing the diagnostic yield of saturation biopsy of the prostate. Eur Urol 2008;53(5):976-81.
11. Girouin N, Mège-Lechevallier F, Tonina Senes A, Bissery A, Rabilloud M, Maréchal JM, et al. Prostate dynamic contrastenhanced MRI with simple visual diagnostic criteria: is it reasonable? Eur Radiol 2007;17(6):1498-509. (Pubitemid 46767598)
12. Villers A, Puech P, Mouton D, Leroy X, Ballereau C, Lemaitre L. Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings. J Urol 2006;176(6 Pt 1):2432-7. (Pubitemid 44665992)
13. Fütterer JJ, Heijmink SW, Scheenen TW, Veltman J, Huisman HJ, Vos P, et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology 2006;241(2):449-58. (Pubitemid 44632891)
14. Lemaitre L, Puech P, Poncelet E, Bouyé S, Leroy X, Biserte J, et al. Dynamic contrast-enhanced MRI of anterior prostate cancer: morphometric assessment and correlation with radical prostatectomy findings. Eur Radiol 2009;19(2):470-80.
15. Lim HK, Kim JK, Kim KA, Cho KS. Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection-a multireader study. Radiology 2009;250(1):145-51.
16. Tanimoto A, Nakashima J, Kohno H, Shinmoto H, Kuribayashi S. Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging. J Magn Reson Imaging 2007;25(1):146-52. (Pubitemid 46095209)
17. Yoshizako T, Wada A, Hayashi T, Uchida K, Sumura M, Uchida N, et al. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer. Acta Radiol 2008;49(10):1207-13.
18. Vargas HA, Akin O, Afaq A, Goldman D, Zheng J, Moskowitz CS, et al. Magnetic resonance imaging for predicting prostate biopsy findings in patients considered for active surveillance of clinically low risk prostate cancer. J Urol 2012;188(5): 1732-8.
19. Dickinson L, Ahmed HU, Allen C, Barentsz JO, Carey B, Futterer JJ, et al. Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. Eur Urol 2011;59(4):477-94.
20. Cheikh AB, Girouin N, Colombel M, et al. Evaluation of T2-weighted and dynamic contrast-enhanced MRI in localizing prostate cancer before repeat biopsy. Eur Radiol 2009;19(3):770-8.
21. Vargas HA, Akin O, Shukla-Dave A, Zhang J, Zakian KL, Zheng J, et al. Performance characteristics of MR imaging in the evaluation of clinically low-risk prostate cancer: a prospective study. Radiology 2012;265(2):478-87.
22. Turkbey B, Choyke PL. Multiparametric MRI and prostate cancer diagnosis and risk stratification. Curr Opin Urol 2012;22(4):310-5.
23. Dickinson L, Ahmed HU, Allen C, Barentsz JO, Carey B, Futterer JJ, et al. Scoring systems used for the interpretation and reporting of multiparametric MRI for prostate cancer detection, localization, and characterization: could standardization lead to improved utilization of imaging within the diagnostic pathway? J Magn Reson Imaging 2013;37(1):48-58.
24. Ocak I, Bernardo M, Metzger G, Barrett T, Pinto P, Albert PS, et al. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters. AJR Am J Roentgenol 2007;189(4):849.
25. Norberg M, Egevad L, Holmberg L, Sparen P, Norlen BJ, Busch C. The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology 1997;50(4):562-6. (Pubitemid 27433216)
26. Rifkin MD, Zerhouni EA, Gatsonis CA, Quint LE, Paushter DM, Epstein JI, et al. Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial. New Engl J Med 1990;323(10):621-6. (Pubitemid 20280191)
27. Beerlage HP, Aarnink RG, Ruijter ET, Witjes JA, Wijkstra H, Van De Kaa CA, et al. Correlation of transrectal ultrasound, computer analysis of transrectal ultrasound and histopathology of radical prostatectomy specimen. Prostate Cancer Prostatic Dis 2001;4(1):56-62. (Pubitemid 32366718)
28. Langer DL, van der Kwast TH, Evans AJ, Trachtenberg J, Wilson BC, Haider MA. Prostate cancer detection with multiparametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI. J Magn Reson Imaging 2009;30(2):327-34.
29. Pallwein L, Mitterberger M, Gradl J, Aigner F, Horninger W, Strasser H, et al. Value of contrast-enhanced ultrasound and elastography in imaging of prostate cancer. Curr Opin Urol 2007;17(1):39-47. (Pubitemid 44901089)
30. Tang J, Yang JC, Li Y, Li J, Shi H. Peripheral zone hypoechoic lesions of the prostate: evaluation with contrast-enhanced gray scale transrectal ultrasonography. J Ultrasound Med 2007;26(12):1671-9. (Pubitemid 350210074)
31. Kundavaram CR, Halpern EJ, Trabulsi EJ. Value of contrastenhanced ultrasonography in prostate cancer. Curr Opin Urol 2012;22(4):303-9.
32. Zhai L, Madden J, Foo WC, Mouraviev V, Polascik TJ, Palmeri ML, et al. Characterizing stiffness of human prostates using acoustic radiation force. Ultrasonic imaging 2010;32(4):201-13.
33. Hoyt K, Castaneda B, Zhang M, Nigwekar P, di Sant'agnese PA, Joseph JV, et al. Tissue elasticity properties as biomarkers for prostate cancer. Cancer Biomark 2008;4(4-5):213-25.
34. Gennisson J-L, et al. Ultrasound elastography: Principles and techniques. Diagn Intervent Imaging 2013, http://dx.doi.org/10.1016/j.diii.2013.01.022.
35. Aigner F, Pallwein L, Junker D, Schäfer G, Mikuz G, Pedross F, et al. Value of real-time elastography targeted biopsy for prostate cancer detection in men with prostate specific antigen 1.25 ng/mL or greater and 4.00 ng/mL or less. J Urol 2010;184(3):913-7.
36. Pallwein L, Mitterberger M, Struve P, Pinggera G, Horninger W, Bartsch G, et al. Real-time elastography for detecting prostate cancer: preliminary experience. BJU Int 2007;100(1):42-6. (Pubitemid 46878542)
37. Salomon G, Köllerman J, Thederan I, Chun FK, Budäus L, Schlomm T, et al. Evaluation of prostate cancer detection with ultrasound real-time elastography: a comparison with step section pathological analysis after radical prostatectomy. Eur Urol 2008;54(6):1354-62.
38. Zhang Y, Tang J, Li YM, Fei X, Lv FQ, He EH, et al. Differentiation of prostate cancer from benign lesions using strain index of transrectal real-time tissue elastography. Eur J Radiol 2012;81(5):857-62.
39. Giurgiu CR, Manea C, Crisan N, Bungardean C, Coman I, Dudea SM. Real-time sonoelastography in the diagnosis of prostate cancer. Med Ultrason 2011;13(1):5-9.
40. Dudea SM, Giurgiu CR, Dumitriu D, Chiorean A, Ciurea A, Botar-Jid C, et al. Value of ultrasound elastography in the diagnosis and management of prostate carcinoma. Med Ultrason 2011;13(1):45-53.
41. Tsutsumi M, Miyagawa T, Matsumura T, Endo T, Kandori S, Shimokama T, et al. Real-time balloon inflation elastography for prostate cancer detection and initial evaluation of clinicopathologic analysis. AJR Am J Roentgenol 2010;194(6):W471-6.
42. Bercoff J, Tanter M, Fink M. Supersonic shear imaging: a new technique for soft tissue elasticity mapping. IEEE Trans Ultrason Ferroelectr Freq Control 2004;51(4):396-409.
43. Correas JM, Khairoune A, Tissier AM, Vassiliu V, Eiss D, Hélénon O. Trans-rectal quantitative shear wave elastography: application to prostate cancer a feasibility study. In: European Congress of Radiology. 2012.
44. Barr RG, Memo R, Schaub CR. Shear wave ultrasound elastography of the prostate: initial results. Ultrasound quarterly 2012;28(1):13-20.
45. Tsutsumi M, Miyagawa T, Matsumura T, Kawazoe N, Ishikawa S, Shimokama T, et al. The impact of real-time tissue elasticity imaging (elastography) on the detection of prostate cancer: clinicopathological analysis. Int J Clin Oncol 2007;12(4): 250-5. (Pubitemid 47262734)
46. Kapoor A, Kapoor A, Mahajan G, Sidhu BS. Real-time elastography in the detection of prostate cancer in patients with raised PSA level. Ultrasound Med Biol 2011;37(9):1374-81.
47. Walz J, Marcy M, Pianna JT, Brunelle S, Gravis G, Salem N, et al. Identification of the prostate cancer index lesion by realtime elastography: considerations for focal therapy of prostate cancer. World J Urol 2011;29(5):589-94.
48. Konig K, Scheipers U, Pesavento A, Lorenz A, Ermert H, Senge T. Initial experiences with real-time elastography guided biopsies of the prostate. J Urol 2005;174(1):115-7. (Pubitemid 40825688)
49. Pallwein L, Mitterberger M, Struve P, Horninger W, Aigner F, Bartsch G, et al. Comparison of sonoelastography guided biopsy with systematic biopsy: impact on prostate cancer detection. Eur Radiol 2007;17(9):2278-85. (Pubitemid 47288264)
50. Nelson ED, Slotoroff CB, Gomella LG, Halpern EJ. Targeted biopsy of the prostate: the impact of color Doppler imaging and elastography on prostate cancer detection and Gleason score. Urology 2007;70(6):1136-40. (Pubitemid 350297373)
51. Kamoi K, Okihara K, Ochiai A, Ukimura O, Mizutani Y, Kawauchi A, et al. The utility of transrectal real-time elastography in the diagnosis of prostate cancer. Ultrasound Med Biol 2008;34(7):1025-32. (Pubitemid 351893145)